title: Modified BEAM conditioning regimen in patients with Hodgkin and non-Hodgkin lymphomas.
authors.forename: Abrahão Elias
authors.initials: AE
authors.lastname: Hallack Neto
authors.forename: Kelli
authors.initials: K
authors.lastname: Borges dos Santos
authors.forename: Angelo
authors.initials: A
authors.lastname: Atalla
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008558:Melphalan / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D005047:Etoposide; D008130:Lomustine; D008558:Melphalan